Latest From EarlySense Ltd.
The positive growth trend seen in Israel's digital health industry is galvanizing big players like Medtronic into action to start developing and recognizing synergistic technologies for future business. Medtech Insight met with members of MindUP, Israel's first digital health incubator and the result of a cross-industry partnership, at the MiXiii Biomed conference in Tel Aviv, to discover how the joint venture is driving the next generation of digital innovations.
Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced May through June.
A $25m series G funding round for the mattress-based remote monitoring firm will help the company drive adoption of its contact-free continuous monitoring technology.
In Vitro Diagnostics
- Monitoring Equipment & Devices
- Therapeutic Areas
- Neurology, Nervous System
- Respiratory, Pulmonary
- Middle East
- Parent & Subsidiaries
- EarlySense Ltd.
- Senior Management
Avner Halperin, CEO
Dov Gal, CFO
Guy Meger, VP, R&D
Yfat Scialom, VP, International Sales & Mktg.
- Contact Info
Phone: (972) 3.752.2330
12 Tsvi St.
Ramat Gan, MA 5250429
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.